List of Excipients in API roflumilast
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing roflumilast
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
AstraZeneca Pharmaceuticals LP | DALIRESP | roflumilast | 0310-0095 | LACTOSE MONOHYDRATE | |
AstraZeneca Pharmaceuticals LP | DALIRESP | roflumilast | 0310-0095 | MAGNESIUM STEARATE | |
AstraZeneca Pharmaceuticals LP | DALIRESP | roflumilast | 0310-0095 | POVIDONE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing roflumilast
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 | CELLULOSE, MICROCRYSTALLINE |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 | CROSCARMELLOSE SODIUM |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 | HYDROXYPROPYL CELLULOSE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for roflumilast
Excipient focus: BUTANE
roflumilast drug variants containing BUTANE
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing BUTANE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM
roflumilast drug variants containing CARBOXYMETHYLCELLULOSE CALCIUM
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing CARBOXYMETHYLCELLULOSE CALCIUM
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
roflumilast drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
Zydus Pharmaceuticals USA Inc | roflumilast | 68382-969 |
Zydus Lifesciences Limited | roflumilast | 70771-1674 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7483 |
>Company | >Ingredient | >NDC |
Excipient focus: CETEARETH-10 PHOSPHATE
roflumilast drug variants containing CETEARETH-10 PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing CETEARETH-10 PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: CETEARYL PHOSPHATE
roflumilast drug variants containing CETEARYL PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing CETEARYL PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
roflumilast drug variants containing CETOSTEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing CETOSTEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
roflumilast drug variants containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
Solco Healthcare US LLC | roflumilast | 43547-005 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
roflumilast drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7483 |
>Company | >Ingredient | >NDC |
Excipient focus: DIETHYLENE GLYCOL MONOETHYL ETHER
roflumilast drug variants containing DIETHYLENE GLYCOL MONOETHYL ETHER
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing DIETHYLENE GLYCOL MONOETHYL ETHER
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: HEXYLENE GLYCOL
roflumilast drug variants containing HEXYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing HEXYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
roflumilast drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
roflumilast drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
Micro Labs Limited | roflumilast | 42571-259 |
Solco Healthcare US LLC | roflumilast | 43547-005 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7483 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
roflumilast drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | roflumilast | 68382-969 |
Zydus Lifesciences Limited | roflumilast | 70771-1674 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
roflumilast drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Aurobindo Pharma Limited | roflumilast | 59651-275 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOBUTANE
roflumilast drug variants containing ISOBUTANE
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing ISOBUTANE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL PALMITATE
roflumilast drug variants containing ISOPROPYL PALMITATE
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing ISOPROPYL PALMITATE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
roflumilast drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
American Health Packaging | roflumilast | 60687-786 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
roflumilast drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Solco Healthcare US LLC | roflumilast | 43547-005 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
roflumilast drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
American Health Packaging | roflumilast | 60687-786 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLENE CHLORIDE
roflumilast drug variants containing METHYLENE CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing METHYLENE CHLORIDE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
roflumilast drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
roflumilast drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
American Health Packaging | roflumilast | 60687-786 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
roflumilast drug variants containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
Aurobindo Pharma Limited | roflumilast | 59651-275 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
roflumilast drug variants containing POLOXAMER 407
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | roflumilast | 68382-969 |
Zydus Lifesciences Limited | roflumilast | 70771-1674 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing POLOXAMER 407
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
roflumilast drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7483 |
Novadoz Pharmaceuticals LLC | roflumilast | 72205-200 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
roflumilast drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
roflumilast drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7483 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPANE
roflumilast drug variants containing PROPANE
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing PROPANE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
roflumilast drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
roflumilast drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
American Health Packaging | roflumilast | 60687-786 |
Zydus Pharmaceuticals USA Inc | roflumilast | 68382-969 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
roflumilast drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
roflumilast drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Solco Healthcare US LLC | roflumilast | 43547-005 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
roflumilast drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
American Health Packaging | roflumilast | 60687-786 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
roflumilast drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Excipient focus: WHITE PETROLATUM
roflumilast drug variants containing WHITE PETROLATUM
Company | Ingredient | NDC |
---|---|---|
Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
>Company | >Ingredient | >NDC |
roflumilast drug variants not containing WHITE PETROLATUM
Company | Ingredient | NDC |
---|---|---|
AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.